Skip to main content

March 23, 2023

Antibiotic Selection & Dose Optimization Guide for Pediatric Patients at least One Month of Age with Gram-Negative Infections

The guide serves as an antibiotic selection and dosing reference for clinicians who are providing care to pediatric patients with infectious diseases caused by particular Gram-negative pathogens (e.g., Pseudomonas aeruginosa, AmpC-producing Enterobacterales). These topics were purposefully identified due to the variety of antibiotic dosing recommendations available for pediatric patients; however, depending on the organism or site of infection, specific dosing regimens are required to optimize the pharmacokinetic and pharmacodynamic (PKPD) parameters of the bug-drug-site interaction.

January 3, 2023

Selected Empiric Antibiotics for Pediatric Patients Admitted to UNC Children’s Hospital

This guidance is intended to be used to assist with empiric antibiotic selection in generally healthy (see below) pediatric patients who are admitted to the hospital and diagnosed with or suspected to have one of the infectious conditions listed in the Tables. This document provides guidance only, and as such this document should not supersede clinical judgment. For example, if a child is known to be recently colonized with MRSA and is being treated for skin and soft-tissue infection, MRSA coverage should be included. Likewise, patients who failed treatment with the recommended (or similar) agent may need alternative therapy. Wherever possible, empiric therapy should be refined based on evolving diagnostic information, microbiologic data, and patient status.